Wadden, T., Tronieri, J. S., Sugimoto, D., Lund, M. T., Auerbach, P., Jensen, C., Rubino, D. ., & Pasamba, C. Q. (2022). LIRAGLUTIDE 3.0 mg AS AN ADJUNCT TO INTENSIVE BEHAVIOR THERAPY IN INDIVIDUALS WITH OBESITY: SCALE IBT 56-WEEK RANDOMIZED, DOUBLEBLIND, PLACEBO-CONTROLLED TRIAL. Journal of the ASEAN Federation of Endocrine Societies, 34(2), 9–10. Retrieved from https://asean-endocrinejournal.org/index.php/JAFES/article/view/1853